KRS 311.7734: Requirements for physician providing abortion-inducing drug --

Examination and follow-up visit.

(1) A qualified physician providing an abortion-inducing drug as defined in KRS

311.7731 shall:

(a) Be credentialed and competent to handle complication management,

including emergency transfer; or

(b) Have a signed contract with an associated physician who is credentialed

to handle complications and produce that signed contract, including the

name and phone number of the associated physician, upon the request of

the cabinet and each pregnant patient.

(2) A qualified physician providing an abortion-inducing drug as defined in KRS

311.7731 shall examine the patient in person and, prior to providing an

abortion-inducing drug, shall:

(a) Independently verify that a pregnancy exists;

(b) Determine the patient's blood type and, if the patient is Rh negative,

provide the patient with an Rh negative information fact sheet and offer to

provide treatment with the prevailing medical standard of care to prevent

harmful fetal or child outcomes or Rh incompatibility in future pregnancies

at the time of the abortion;

(c) Inform the patient that the remains of the unborn child may be visible in

the process of completing the abortion; and

(d) Document, in the patient's medical chart, the gestational age and

intrauterine location of the pregnancy, and whether the patient received

treatment for Rh negativity, as diagnosed, by the most accurate standard

of medical care.

(3) (a) The qualified physician or an agent of the qualified physician providing

any abortion-inducing drug as defined in KRS 311.7731 shall schedule a

follow-up visit for the patient for approximately seven (7) to fourteen (14)

days after administration of the abortion-inducing drug to confirm that the

pregnancy is completely terminated and to assess any degree of

bleeding.

(b) The qualified physician shall make all reasonable efforts to ensure that

the patient returns for the scheduled appointment.

(c) A brief description of the efforts made to comply with this subsection,

including the date, time, and identification by name of the person making

such efforts, shall be included in the patient's medical record.